Purpose: To report our preliminary experience with the use of intravoxel incoherent motion (IVIM) diffusionweighted magnetic resonance imaging (DW-MRI) and dynamic contrast-enhanced (DCE)-MRI alone and in combination for the diagnosis of liver cirrhosis.
NONINVASIVE DIAGNOSIS of liver fibrosis and cirrhosis in patients with chronic liver disease is critical, as cirrhotic patients are at higher risk of endstage liver disease, portal hypertension, and hepatocellular carcinoma (HCC) (1) . In addition, cirrhotic patients with chronic viral hepatitis are less likely to respond to antiviral therapy (2, 3) .
Magnetic resonance imaging (MRI) is a promising method for assessment of diffuse liver disease, given the potential for multiparametric information. In vivo metrics obtained with both diffusion-weighted (DW) MRI (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) and dynamic contrast-enhanced (DCE) MRI (15, 16) have been shown to represent potential markers of fibrosis and cirrhosis. The mechanism of perfusion changes in liver fibrosis are better understood than changes observed with DW-MRI. Depending on the acquisition parameters, apparent diffusion coefficient (ADC; Â10 À3 mm 2 /s) is known to reflect variable combinations of diffusion and perfusion effects. The concept of IVIM (intravoxel incoherent motion)-initially described by Le Bihan et al (17) (18) (19) (20) in brain imaging-has the potential to measure both true molecular diffusion and incoherent motion of water molecules in the capillary network, known as pseudodiffusion. Because cirrhosis involves accumulation of extracellular matrix that may affect both true diffusion and microcirculation, IVIM DW-MRI should be sensitive to cirrhotic changes. However, the IVIM model has been rarely described in the liver (21) (22) (23) . Yamada et al (21) were the first to assess IVIM DW-MRI in abdominal organs, although they used only a limited number of b-values (30, À3 mm 2 /s) and PF (perfusion fraction). There are no published reports on the comparison and combination of DW-and DCE-MRI to diagnose liver fibrosis or cirrhosis.
The purpose of our study was to report our preliminary experience with the use of IVIM DW-MRI and DCE-MRI alone and in combination for the diagnosis of liver cirrhosis.
MATERIALS AND METHODS

Study Design and Patient Population
This was a Health Insurance Portability and Accountability Act (HIPAA)-compliant prospective study that was approved by our local Institutional Review Board. Informed signed consent was obtained from all subjects. Thirty subjects (M/F 18/12, mean age 48 years, range 23-89 years) were prospectively enrolled from July 2008 to March 2009. The subjects were stratified as noncirrhotic (n ¼ 16) or cirrhotic (n ¼ 14) based on clinical history, liver function tests, MRI findings, and pathologic data.
The noncirrhotic group included the following subjects: nine healthy volunteers (M/F 8/1, mean age 30 years, range 23-43 years) without history of chronic liver disease or significant alcohol intake, assessed only with IVIM DW-MRI. Six patients (M/F 0/6, mean age 45 years, range 23-70 years) without a history of chronic liver disease or significant alcohol intake and with normal liver function tests, evaluated for benign liver lesions (hemangiomas, adenomas, or focal nodular hyperplasia). A 35-year-old female patient with periportal fibrosis of unknown etiology (diagnosed with partial hepatectomy for an indeterminate liver lesion). The cirrhotic group included 14 patients (M/F 10/4, mean age 62 years, range 26-89 years) with a history of chronic liver disease. Cirrhosis was proven by histopathology (n ¼ 3) or MRI findings showing liver nodularity and portal hypertension (n ¼ 11). Cirrhosis was attributed to chronic hepatitis C (n ¼ 9), alcohol intake (n ¼ 3), or autoimmune hepatitis (n ¼ 2). Four of these patients had focal lesions consistent with HCC. A total of 17 patients (four noncirrhotic and 13 cirrhotic) underwent both IVIM and DCE-MRI.
IVIM DW-MRI
MRI was performed using one of three 1.5 T systems (Magnetom Avanto, Symphony and Sonata, Siemens Healthcare, Erlangen, Germany). IVIM DW-MRI was acquired before any contrast administration in 27 subjects (three patients had only DCE-MRI without DW-MRI), using free breathing or navigator-echo triggered (PACE: prospective acquisition correction, Siemens Healthcare) (24) single-shot echoplanar imaging (SS EPI) acquisition (parameters in Table 1 ). PACE and free-breathing acquisitions were performed in 21 and 10 subjects, respectively (four volunteers had both PACE and free-breathing acquisitions performed). Coronal over transverse acquisition was chosen to match the coronal acquisition used with DCE-MRI.
DCE-MRI
DCE-MRI was performed in 20 patients (nine healthy volunteers and one patient with renal insufficiency did not have contrast injection). Perfusion imaging of the whole liver was performed using a 3D interpolated spoiled gradient-recalled echo sequence in the coronal plane. Patients fasted for 6 hours before the study. The arms were elevated to minimize aliasing artifacts. Three acquisitions were performed before contrast injection, and the first postcontrast acquisition started at the end of the injection of 10 mL of gadobenate dimeglumine (MultiHance, Bracco Diagnostics, Princeton, NJ) followed by a 20-mL saline flush injected at 5 mL/sec using an MR-compatible power injector (Spectris, Medrad, Indianola, PA). Fifty coronal volumetric acquisitions images were acquired every 3.5-5 seconds for %3-4 minutes (parameters in Table 1 ). Patients were instructed to suspend respiration at end expiration (in order to minimize misregistration) during all acquisitions, with the first breath hold lasting %25-30 seconds and subsequent free shallow breathing. The rationale of coronal plane imaging was to minimize flow-related enhancement of the aorta (25) . IVIM DW-MRI and DCE-MRI were incorporated into the routine MRI protocol and added %10 minutes to the total imaging time.
Image Analysis
MR images were assessed by three observers (observer 1, who was a body MRI fellow; observer 2, who was a medical student; and observer 3, a radiologist with 5 years experience in body MRI).
IVIM DW-MRI Analysis
ROI (region of interest) placement. All ROIs were manually positioned by observers 1 and 2 in consensus on SS EPI diffusion images on a commercial workstation (Syngo, Siemens Healthcare) for all b-values. A large ROI (2-3 cm) was positioned in the right hepatic lobe on three consecutive slices centered on the main portal vein (Fig. 1 ). ROIs were placed away from lesions, confluent fibrosis, and large intrahepatic vessels. The left hepatic lobe was excluded due to potential cardiac motion artifacts that may artificially increase values of IVIM parameters. Mean signal intensity (SI) was measured within each ROI, and values of three ROIs (from three slices) were averaged for biexponential fitting (see below).
In addition, for each slice position an ROI was placed over air for b ¼ 1000 s/mm 2 images. This value was compared to SI of the right hepatic lobe as detailed above. All slice positions or entire datasets were excluded when the ratio of the liver signal intensity to that in the air ROI (defined here as signal-tonoise ratio, SNR) was less than 2 and thus were potentially biased by Rician noise (26) .
Segmented biexponential fitting (Fig. 2) . The fitting was performed by an expert observer (observer 4, with 12 years experience in DW-MRI) to derive PF, D, D*, and ADC. The values obtained on a per-patient basis were calculated by averaging the three ROI measurements.
The IVIM concept (17) is based on the assumption that water molecules in a voxel can be separated into compartments can be identified and characterized as described below:
Since a simultaneous nonlinear fit for all parameters in Eq. [1] can be problematic in cases of low perfusion fraction, limited sampling, or low precision (27) , a more stable ''segmented'' analysis procedure was adopted as follows, and as employed in other reports (28) (29) (30) . Typically, D* is significantly greater than D (17) by a factor of %10, so that when b value is greater than 200 s/mm 2 , the influence of the pseudodiffusion term on the signal decay is quite small. Thus, in the higher b-value regime, Eq. [1] can then be simplified into a linear fit equation whereby D can be estimated:
Here S int is the b ¼ 0 intercept of the high b-value exponential fit, which allows the perfusion fraction to be estimated according to:
With D and PF values determined by using Eq. [2] , D* values can be calculated by using a partially constrained nonlinear regression algorithm based on Eq.
[1]. The ADC was obtained by using all b-values (0-1000 s/mm 2 ) and then fitted to the equation:
All regression algorithms and parametric map generation of the parameters PF, D, D*, and ADC were performed with custom-written code written in IgorPro software (Wavemetrics, Lake Oswego, OR). The above algorithm was employed primarily for the DW-MRI ROI analysis, from which all quantitative metrics were derived for correlation with other data. The same procedure was applied on a voxelwise basis to select normal and cirrhotic cases for pure qualitative illustration, since the SNR per voxel is significantly less than that of the large ROI analysis.
Assessment of Reproducibility of IVIM Parameters
Test/retest evaluation was performed to assess reproducibility by repeating IVIM DWI in the same subjects within a 1-2 week time period on the same MR unit without any intervention in the interval. IVIM DW-MRI was repeated in five subjects (one patient with noncirrhotic liver and four volunteers) using PACE (n ¼ 5) and free breathing acquisitions (n ¼ 4).
DCE-MRI Analysis
ROI placement. The images were transferred to a PC for analysis. Home-grown software was used for analysis (Firevoxel). To determine the vascular input functions (VIF), ROIs were manually drawn on the main portal vein (at the level of the porta hepatis) and proximal abdominal aorta (at the level of the celiac axis, used as a surrogate of the hepatic artery). ROIs for the portal vein were drawn for each timeframe to correct for spatial misregistration due to respiratory motion. In addition, six liver ROIs (measuring 2-3 cm, 3 in the right lobe and 3 in the left lobe) were placed by observers 2 and 3 in consensus. Large vascular structures or liver lesions were avoided.
Model-free perfusion parameters. All perfusion computations were performed by an expert observer (observer 5, with 20 years in perfusion modeling and image processing). For each liver region three parameters (TTP [time to peak], upslope, and IAUC60 [area under the curve at 60 sec]) were defined using simplified, model-free computations that did not require information about arterial or portal vein input functions. From each signal activity curve S(t) the values of rise time t rise and peak time t peak were identified. The value t rise was defined as the earliest sample with signal exceeding the baseline threshold: where M 0 was the mean value M 0 and s 0 the standard deviation of the signal measured during the first five (ie, preinjection) acquisitions. The value t peak was the timepoint at which S(t) reached its maximum. These timepoints t rise and t peak served to define TTP, peak concentration c max , and average upslope U according to:
C(t) in the above equation denotes the concentrationversus-time curve derived from S(t). In addition, the area under the time activity curve of gadolinium contrast over 60 seconds from the start of contrast enhancement was quantified (IAUC60).
Perfusion modeling. SI measurements were normalized by subtracting the SI value of the initial unenhanced image from the SI measurements of the subsequent enhanced images, then dividing the difference by the initial SI value. SI curves were then obtained from all ROI data (Fig. 3) . A linear relationship was assumed between SI and gadolinium concentration for the range of expected concentrations in the liver (0.0-0.5 mM/L) and blood (0-5 mM/L). Our conversion was therefore based on the approximation: c ¼ k (S À S 0 )/S 0 (31), in which S 0 is precontrast SI, S is postcontrast SI, and k the scaling constant (0.395 for liver and 0.201 for blood). These constants are based on prior phantom and human calibration study (32) . The resulting time-activity curves were fitted using a dual-input single compartmental model which was validated previously (15, 16, 33) . This model reflects the dual blood supply from the portal vein and hepatic artery received by the liver. The general equation for the dual-input kinetic model is:
where C a (t), C p (t), and C L (t) represent the concentrations of the contrast in the aorta, the portal vein, and the liver, respectively; d represents the transit times from the aorta region to the liver region of interest, k 1a represents the aortic inflow rate constant, k 1p the portal venous inflow rate constant, and k 2 the outflow rate constant. A fitting procedure was performed to determine k 1a , k 1p , k 2 , and d using locally developed software written in Cþþ. The distribution volume (DV in %) of Gd-contrast through the liver compartment was calculated as DV ¼ 100 (k 1a þ k 1p )/k 2 , and mean transit time (MTT in sec) as 1/k 2 . MTT is the average time it takes a Gd molecule to traverse the liver from arterial/portal entry to venous exit. Inflow constants k 1a , k 1p , were converted to arterial and portal flow rates F a (arterial liver blood flow), F p (portal liver blood flow), both expressed in ml/100g/min, and then used to compute the total flow (F a þ F p ) as well as the arterial fraction (ART, in %)
Statistical Analysis SAS v. 9.0 (Cary, NC) was used for statistical computations. All statistical analyses employed result from ROI analysis. An exact Mann-Whitney test was used to compare cirrhotic and noncirrhotic subjects in terms of each imaging measure. Binary logistic regression was used to derive models to predict cirrhosis using sets of two or more imaging measures. Receiver operating characteristic (ROC) curve analysis was used to identify cutoff values for the imaging measures that maximized the average of sensitivity and specificity when the threshold was used to define patients as test positive or test negative for cirrhosis.
A generalized estimating equations (GEE) model was Figure 3 . Time activity curves obtained with DCE-MRI in the same patients as in Fig. 2 used to compare sensitivity and specificity of IVIM and DCE-MRI parameters. All reported P values are two-sided. Each of PF and D* were correlated with DCE-MR parameters using the Pearson correlation test. Statistical significance was defined as P < 0.05. Reproducibility of imaging parameters was evaluated using coefficient of variation (CV ¼ SD/mean of 2 measures) analysis.
RESULTS
IVIM DW-MRI Parameters (Table 2) ROI analysis results showed that ADC values were significantly higher than D values in both the noncirrhotic and cirrhotic subjects (P ¼ 0.001 and 0.002, respectively), confirming the perfusion effect on ADC values. All IVIM parameters (ADC, D*, D, PF) were significantly reduced in the cirrhotic group compared to the noncirrhotic group (P ¼ 0.0071-0.0392) (Table 2, Figs. 2, 4) . The most significant difference was observed for ADC. The relationships shown in Table 2 and Figure 4 , derived from robust large ROI analysis, are qualitatively consistent with example parametric maps of IVIM parameters in a normal and cirrhotic patient (Fig. 5) . Although spatial textures are complex, the mean values of each IVIM parameter across the liver are lower in the cirrhotic versus normal patient.
Reproducibility of IVIM parameters (in the subset of patients in whom repeat PACE or free-breathing DWI was performed) was excellent for ADC and D, good for PF, and fair for D* (Table 3) . Reproducibility was higher with the navigator triggered acquisition. (Table 4) TTP, DV, and MTT were all significantly increased in the cirrhotic group when compared to the noncirrhotic group (P ¼ 0.002-0.0187) ( Table 4, Figs. 3, 6 ). F a and ART were increased, whereas upslope and IAUC60 were decreased in cirrhosis, with a trend toward significance (P ¼ 0.0791-0.0913), likely due to sample size. Portal venous flow (F p ) and total liver flow (F a þ F p ) were decreased in cirrhosis without reaching significance.
DCE-MRI Parameters
Correlation Between IVIM and DCE-MRI Parameters
There was no significant correlation between each of PF and D* with DCE-MR parameters (Pearson correlation coefficients ranging from À0.35 to 0.40; P > 0.14, Table 5 ).
Diagnostic Performance of IVIM DW-and DCE-MRI Alone and in Combination (Table 6)
Stepwise variable selection in the context of logistic regression identified ADC as the best predictor of cirrhosis from among the IVIM measures (Az 0.808, sensitivity 84.6%, specificity 71.4%). The stepwise variable selection identified DV and TTP as the best predictors of cirrhosis from among the DCE measures (Az 0.952, sensitivity 85.7%, specificity 100.0% for both) followed by MTT (Az 0.845, sensitivity 100.0%, specificity 83.3%), and IAUC60 (Az 0.804, sensitivity 85.7%, specificity 75.0%). The Az of DV and TTP were higher than that of ADC; however, the comparison between IVIM and DCE-MR parameters using the GEE model showed no significant difference (P ¼ 0.9281 for sensitivity and 1.0 for specificity).
In the 17 patients who had both IVIM DW-and DCE-MRI, the combination of ADC with TTP and DV provided 84.6% sensitivity (11/13), 100% specificity (4/4), 100% positive predictive value (11/11), 66.6% negative predictive value (4/6), and 88.2% (15/17) accuracy for diagnosing cirrhosis (Fig. 7) . All four noncirrhotic patients had decreased TTP and DV, and the 11/13 cirrhotic patients had decreased ADC and increased TTP or increased DV.
DISCUSSION
In our study we demonstrated altered IVIM (ADC, PF, D*, and D) and DCE-MR parameters (TTP, DV, and MTT) in liver cirrhosis, with excellent diagnostic accuracy for diagnosing cirrhosis using ADC and TTP-DV. In addition, we showed that the combination of ADC with TTP and DV yielded 84.6% sensitivity and 100% specificity for diagnosing cirrhosis. To our knowledge, this is the first study reporting the use of combined IVIM and DCE-MR acquisitions in liver imaging.
Patients with chronic hepatitis (including mostly viral, alcoholic, and nonalcoholic steatohepatitis) are at high risk of developing liver fibrosis and cirrhosis (1). Accurate diagnosis of liver cirrhosis is critical, as cirrhotic patients are at higher risk of endstage liver *n: number of subjects (four subjects had both PACE and free breathing IVIM repeated, and one subject had only PACE IVIM DW-MRI repeated).
disease, portal hypertension, and HCC. The degree of fibrosis is commonly determined from liver biopsy, used to assess prognosis and guide therapy (34) . However, liver biopsy is relatively invasive, expensive, limited by sample size, and difficult to repeat (35) (36) (37) (38) (39) (40) . Thus, noninvasive tools to assess the degree of injury and fibrosis of the whole liver are urgently needed. DW-MRI (4-14) and DCE CT or MRI (15, 16, 33, 41) parameters have been shown to be potentially useful for detection of liver fibrosis and cirrhosis, with a reported range of areas under the curve of 0.896-0.93 (11) (12) (13) for diagnosis of advanced fibrosis or cirrhosis. Most of these diffusion studies showing decreased liver ADC in cirrhosis (4-9,13) or fibrosis (10) (11) (12) 14) compared to normal liver or mild degrees of fibrosis have quantified diffusion using a monoexponential fit, and have assumed pure diffusion restriction in relation with extracellular matrix accumulation. However, our findings and those from other investigators (21, 23, 42) suggest that both pure molecular diffusion and capillary perfusion contribute to signal attenuation in liver diffusion imaging. This is primarily Large differences in D* may also be attributed to fitting errors, as this parameter typically displays the largest fitting uncertainty in IVIM studies. Our results suggest that PF is lower in the cirrhotic group than in the noncirrhotic group, and our data support the theory that differences in total ADC between noncirrhotic and cirrhotic patients has a significant perfusional component but restriction of Brownian motion still plays a role at higher b-values. In our study, ADC was still the best IVIM parameter in terms of accuracy, with the best reproducibility, likely due to increased data points (including low and large b-values). Previous reports have shown that advanced fibrosis and cirrhosis lead to reduced portal venous flow and increased arterial flow (known as the arterial buffer response) (44) , as well as increased MTT and DV measured with DCE CT or MRI (15, 16, 33, 41) . A recent study has showed that DV was the best predictive parameter for diagnosing advanced fibrosis and cirrhosis (Az of 0.824, sensitivity of 76.9%, and specificity of 78.5% for DV ! 21.05%) (16) . The current study showed higher Az for DV and MTT compared to the prior study by Hagiwara et al (16) , which likely relates to a different patient selection (intermediate stages of fibrosis were not included in the current study). Model-free DCE-MR parameters have never been described before for the diagnosis of liver cirrhosis, and these may have a role in future studies, as these parameters are easy to quantify, without the need for vascular input function.
The relationship between perfusion parameters measured with IVIM versus those measured with DCE-MRI is unclear. In an opinion article, Le Bihan and Turner (45) suggested that the combination of PF and D* may potentially provide useful data for microcirculation physiology (PF measures the fractional volume of capillary blood flowing in each voxel, and D* is proportional to the mean capillary segment length and to average blood velocity). They also suggested that CBF (cerebral blood flow) is directly proportional to the product PF Â D*. In a contradictive opinion article, Henkelman (46) suggested that IVIM does not measure tissue perfusion as does DCE-MRI, as it is more sensitive to blood volume transit through a voxel. Data corroborating or contradicting these opinions is sparse, even in neuroimaging. For example, Wirestam et al (30) correlated brain IVIM parameters with dynamic susceptibility-contrast (DSC) MRI (calculating cerebral blood volume and flow, CBV and CBF) in 28 volunteers. They demonstrated a moderate significant correlation between PF and CBV (r ¼ 0.56, P < 0.001) using asymptotic fitting (ie, segmented analysis). A key point in the comparison of IVIM and DCE or DSC MRI techniques is the effect of compartmental exchange. The evolution time of the DW-MRI sequence (%100 msec) is insufficient for significant water exchange and thus the signal can be interpreted as separate intra-and extravascular compartments, with the parameters PF and D* referring to the intravascular compartment. Conversely, DCE-MRI tracks contrast continuously over much longer periods (several minutes) and thus necessarily involves intravascular, extravascular, and exchange dynamics. Correspondingly, of the parameters of the DCE-MRI model, eg, those reported in this study, none exclusively reflect microvascular volume or flow, but instead some composite encompassing total tracer transit. DSC MRI, on the other hand, employs susceptibility contrast on short timescales and, particularly for vasculature with a blood-brain barrier, also provides access to purely intravascular parameters (eg, CBF and CBV), motivating the aforementioned comparison of IVIM and DSC-MRI metrics. Indeed, since ''perfusion'' usually connotes not only vascularity but also the extravasation of blood products to surrounding parenchyma, the terms ''perfusion fraction'' or ''perfusion-induced pseudodiffusion'' can be misleading. While the terms historically arose to differentiate vascular from parenchymal effects in DW-MRI, care must be taken in attempts to reconcile them with DCE-MRI, which has distinctly different biophysical sensitivity. Finally, other effects unique to hepatic tissue may confound the association of IVIM exclusively with perfusive vascularity, including fast flow of bile ducts and venous drainage.
Based on this perspective and the current study results, we can confidently suggest that liver perfusion measurements with IVIM are not equivalent to perfusion parameters obtained with DCE-MRI, with no correlations observed. Therefore, we do not believe that IVIM can be used as a surrogate for DCE-MR perfusion. Since the parameters measured with each method do not relate, it is very attractive to combine the two methods for improved diagnostic accuracy, as shown in our patient population. This could be further assessed for prospective detection of intermediate stages of fibrosis.
An important issue with DW-and DCE-MRI is reproducibility. Moteki and Horikoshi (22) reported a /s, TTP !57.14 sec, DV !30.20%). All four noncirrhotic patients had decreased TTP and DV, and 11 cirrhotic patients had decreased ADC and increased TTP or increased DV. The combination of ADC with TTP and DV provided 84.6% sensitivity (11/13), 100% specificity (4/4), 100% positive predictive value (11/11), 66.6% negative predictive value (4/6), and 88.2% (15/17) ), and they did not report CV of ADC and PF. A recent study on volunteers showed mean CV of 12.8% for liver ADC measurement using free-breathing DW-MRI (47) . More recently, Koh et al (48) found better reproducibility of ADC total (using all b-values: 0, 50, 100, 250, 500, and 750 s/mm 2 ) and ADC high (using 100, 250, 500, and 750 s/mm 2 ), compared to ADC low (using 0, 50, and 100 s/mm 2 ). In our study we found good to excellent reproducibility of ADC, D, and PF, especially with the navigator triggered acquisition (CV <6% for ADC and D, and <12% for PF). D* had the worse reproducibility (with CV of 14.6% and 39.1% for navigator triggered and free breathing acquisitions, respectively). Regarding reproducibility of liver perfusion measurements, Miyazaki et al (49) recently reported excellent reproducibility of hepatic perfusion index (a semiquantitative perfusion parameter) measured in patients treated with an antiangiogenic compound.
We did not measure reproducibility of DCE-MR parameters in our study, and this could be assessed in a separate study.
Our study had several limitations. The ability to recruit noncirrhotic patients prospectively for the DCE-MRI portion of study was limited and as a result only four patients were included in this portion of the study. In the cirrhotic group, histopathologic confirmation was only available for three patients. Furthermore, we did not assess intermediate stages of fibrosis in this evaluation. One patient included in our noncirrhotic group was found to have heterogeneous areas of periportal fibrosis on pathology and this may have negatively skewed our results. Future studies assessing different stages of fibrosis using IVIM and DCE-MR parameters may be conducted. In our initial experience, only five b-values less than or equal to 200 s/mm 2 were implemented. Because our aim was to evaluate perfusion-related diffusion parameters, a greater number of b-values less than 200 s/mm 2 would be better at showing more subtle differences in perfusion-related parameters (PF and D*) or lack thereof. A final limitation of the study protocol could arise from injecting a constant volume of 10 mL of gadolinium contrast in patients of different weight. Some of the model-free perfusion parameters (including c max , upslope, and IAUC60) could be confounded by this dose-related variability.
In conclusion, our findings show that perfusion and diffusion are both affected in cirrhosis, IVIM perfusion parameters do not correlate with DCE-MR parameters, and that the combination of diffusion and DCE-MR parameters (ADC and DV-TTP) provides excellent diagnostic performance for the detection of liver cirrhosis.
